Trex Wind-down, Inc. engages in the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibroma in tuberous sclerosis complex, and other sclerotic skin diseases. The company was founded on August 30, 2010 and is headquartered in Warren, NJ.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company